» Articles » PMID: 19940135

Targeting of Integrin Beta1 and Kinesin 2alpha by MicroRNA 183

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Nov 27
PMID 19940135
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA 183 (miR-183) has been reported to inhibit tumor invasiveness and is believed to be involved in the development and function of ciliated neurosensory organs. We have recently found that expression of miR-183 increased after the induction of cellular senescence by exposure to H(2)O(2). To gain insight into the biological roles of miR-183 we investigated two potential novel targets: integrin beta1 (ITGB1) and kinesin 2alpha (KIF2A). miR-183 significantly decreased the expression of ITGB1 and KIF2A measured by Western blot. Targeting of the 3'-untranslated region (3'-UTR) of ITGB1 and KIF2A by miR-183 was confirmed by luciferase assay. Transfection with miR-183 led to a significant decrease in cell invasion and migration capacities of HeLa cells that could be rescued by expression of ITGB1 lacking the 3'-UTR. Although miR-183 had no effects on cell adhesion in HeLa cells, it significantly decreased adhesion to laminin, gelatin, and collagen type I in normal human diploid fibroblasts and human trabecular meshwork cells. These effects were also rescued by expression of ITGB1 lacking the 3'-UTR. Targeting of KIF2A by miR-183 resulted in some increase in the formation of cells with monopolar spindles in HeLa cells but not in human diploid fibroblast or human trabecular meshwork cells. The regulation of ITGB1 expression by miR-183 provides a new mechanism for the anti-metastatic role of miR-183 and suggests that this miRNA could influence the development and function in neurosensory organs, and contribute to functional alterations associated with cellular senescence in human diploid fibroblasts and human trabecular meshwork cells.

Citing Articles

Integrated Profiling of Extracellular Vesicle microRNA Impact on Trabecular Meshwork mRNA Expression: Insights From Microarray Analysis.

Cohen-Davidi E, Feinstein V, Knyazer B, Beit-Yannai E, Veksler-Lublinsky I Invest Ophthalmol Vis Sci. 2024; 65(14):38.

PMID: 39728693 PMC: 11684117. DOI: 10.1167/iovs.65.14.38.


miRNA-ome plasma analysis unveils changes in blood-brain barrier integrity associated with acute liver failure in rats.

Orzel-Gajowik K, Milewski K, Zielinska M Fluids Barriers CNS. 2023; 20(1):92.

PMID: 38066639 PMC: 10709860. DOI: 10.1186/s12987-023-00484-7.


Regulation of miRNA expression by α4β1 integrin-dependent multiple myeloma cell adhesion.

Rodriguez-Garcia Y, Martinez-Moreno M, Alonso L, Sanchez-Vencells A, Arranz A, Daga-Millan R EJHaem. 2023; 4(3):631-638.

PMID: 37601846 PMC: 10435698. DOI: 10.1002/jha2.756.


Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer.

Verhoeff T, Holloway A, Dickinson J Cell Oncol (Dordr). 2022; 46(2):239-250.

PMID: 36512308 PMC: 10060301. DOI: 10.1007/s13402-022-00752-y.


5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.

Li X, Michels B, Tosun O, Jung J, Kappes J, Ibing S J Exp Clin Cancer Res. 2022; 41(1):190.

PMID: 35655310 PMC: 9161486. DOI: 10.1186/s13046-022-02380-8.


References
1.
Puklin-Faucher E, Sheetz M . The mechanical integrin cycle. J Cell Sci. 2009; 122(Pt 2):179-86. PMC: 6518156. DOI: 10.1242/jcs.042127. View

2.
Wederell E, de Iongh R . Extracellular matrix and integrin signaling in lens development and cataract. Semin Cell Dev Biol. 2006; 17(6):759-76. DOI: 10.1016/j.semcdb.2006.10.006. View

3.
Chow J, Liton P, Luna C, Wong F, Gonzalez P . Effect of cellular senescence on the P2Y-receptor mediated calcium response in trabecular meshwork cells. Mol Vis. 2007; 13:1926-33. PMC: 2185512. View

4.
Ohtani N, Mann D, Hara E . Cellular senescence: its role in tumor suppression and aging. Cancer Sci. 2009; 100(5):792-7. PMC: 11158751. DOI: 10.1111/j.1349-7006.2009.01123.x. View

5.
Cannistra S, Ottensmeier C, Niloff J, Orta B, DiCarlo J . Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol. 1995; 58(2):216-25. DOI: 10.1006/gyno.1995.1214. View